Cargando…
Immunological Cross-Reactivity and Neutralisation of European Viper Venoms with the Monospecific Vipera berus Antivenom ViperaTAb
Medically important cases of snakebite in Europe are predominately caused by European vipers of the genus Vipera. The mainstay of snakebite therapy is polyclonal antibody therapy, referred to as antivenom. Here we investigate the capability of the monospecific V. berus antivenom, ViperaTAb(®), to cr...
Autores principales: | Casewell, Nicholas R., Al-Abdulla, Ibrahim, Smith, David, Coxon, Ruth, Landon, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147594/ https://www.ncbi.nlm.nih.gov/pubmed/25153254 http://dx.doi.org/10.3390/toxins6082471 |
Ejemplares similares
-
Vipera berus berus Venom from Russia: Venomics, Bioactivities and Preclinical Assessment of Microgen Antivenom
por: Al-Shekhadat, Ruslan I., et al.
Publicado: (2019) -
Proteome and Peptidome of Vipera berus berus Venom
por: Bocian, Aleksandra, et al.
Publicado: (2016) -
Comparison of Preclinical Properties of Several Available Antivenoms in the Search for Effective Treatment of Vipera ammodytes and Vipera berus Envenoming
por: Kurtović, Tihana, et al.
Publicado: (2021) -
PLA(2) Inhibitor Varespladib as an Alternative to the Antivenom Treatment for Bites from Nikolsky’s Viper Vipera berus nikolskii
por: Zinenko, Oleksandr, et al.
Publicado: (2020) -
Biochemistry and toxicology of proteins and peptides purified from the venom of Vipera berus berus
por: Siigur, Jüri, et al.
Publicado: (2022)